ATE836T1 - Kontrollreagens fuer die bestimmung der heparinaktivitaet. - Google Patents
Kontrollreagens fuer die bestimmung der heparinaktivitaet.Info
- Publication number
- ATE836T1 ATE836T1 AT80100222T AT80100222T ATE836T1 AT E836 T1 ATE836 T1 AT E836T1 AT 80100222 T AT80100222 T AT 80100222T AT 80100222 T AT80100222 T AT 80100222T AT E836 T1 ATE836 T1 AT E836T1
- Authority
- AT
- Austria
- Prior art keywords
- determination
- heparin activity
- control reagents
- heparin
- mole
- Prior art date
Links
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 title abstract 3
- 239000003153 chemical reaction reagent Substances 0.000 title abstract 3
- 229960002897 heparin Drugs 0.000 title abstract 3
- 229920000669 heparin Polymers 0.000 title abstract 3
- 102000004411 Antithrombin III Human genes 0.000 abstract 1
- 108090000935 Antithrombin III Proteins 0.000 abstract 1
- 108010039627 Aprotinin Proteins 0.000 abstract 1
- 102000007562 Serum Albumin Human genes 0.000 abstract 1
- 108010071390 Serum Albumin Proteins 0.000 abstract 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 abstract 1
- 229930006000 Sucrose Natural products 0.000 abstract 1
- 229960005348 antithrombin iii Drugs 0.000 abstract 1
- 229960004405 aprotinin Drugs 0.000 abstract 1
- 239000012928 buffer substance Substances 0.000 abstract 1
- 235000013681 dietary sucrose Nutrition 0.000 abstract 1
- ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 abstract 1
- HLWRUJAIJJEZDL-UHFFFAOYSA-M sodium;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetate Chemical compound [Na+].OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC([O-])=O HLWRUJAIJJEZDL-UHFFFAOYSA-M 0.000 abstract 1
- 229960004793 sucrose Drugs 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
- G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- G01N2400/38—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence, e.g. gluco- or galactomannans, Konjac gum, Locust bean gum or Guar gum
- G01N2400/40—Glycosaminoglycans, i.e. GAG or mucopolysaccharides, e.g. chondroitin sulfate, dermatan sulfate, hyaluronic acid, heparin, heparan sulfate, and related sulfated polysaccharides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/106664—Blood serum or blood plasma standard or control
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2903701A DE2903701C2 (de) | 1979-01-31 | 1979-01-31 | Kontrollreagens für die Bestimmung der Heparinaktivität |
| EP80100222A EP0014349B1 (de) | 1979-01-31 | 1980-01-17 | Kontrollreagens für die Bestimmung der Heparinaktivität |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE836T1 true ATE836T1 (de) | 1982-04-15 |
Family
ID=6061834
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT80100222T ATE836T1 (de) | 1979-01-31 | 1980-01-17 | Kontrollreagens fuer die bestimmung der heparinaktivitaet. |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US4301028A (de) |
| EP (1) | EP0014349B1 (de) |
| JP (1) | JPS55103463A (de) |
| AT (1) | ATE836T1 (de) |
| DE (2) | DE2903701C2 (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3019612A1 (de) * | 1980-05-22 | 1981-11-26 | Boehringer Mannheim Gmbh, 6800 Mannheim | Stabilisiertes thrombinpraeparat |
| DE3265781D1 (en) | 1981-05-21 | 1985-10-03 | Akzo Nv | New anti-thromboticum based on polysacharides, method for its preparation and pharmaceutical compositions |
| JPS58220697A (ja) * | 1982-06-15 | 1983-12-22 | Green Cross Corp:The | アンテイトロンビン−３の活性測定方法及びその方法を使用するキツト |
| SE8702556D0 (sv) * | 1987-06-18 | 1987-06-18 | Kabivitrum Ab | Bestemning av vid proteolys aktiva komponenter |
| US5312745A (en) * | 1987-06-18 | 1994-05-17 | Chromogenix Ab | Determination of components active in proteolysis |
| JP3055933B2 (ja) * | 1989-07-20 | 2000-06-26 | アナリティカル・コントロール・システムズ・インコーポレーテッド | 改良された安定な凝固対照 |
| US5939325A (en) * | 1989-07-20 | 1999-08-17 | Analytical Control Systems, Inc. | Stable whole blood coagulation controls |
| US5296377A (en) * | 1992-12-15 | 1994-03-22 | Boehringer Mannheim Corporation | Control reagent containing a hydroxylamine or an antioxidant |
| US5385825A (en) * | 1993-07-20 | 1995-01-31 | Emerald Biomedical Sciences, Inc. | Composition for processing bodyfluids, method of processing bodyfluids and products made from bodyfluids |
| US6194394B1 (en) | 1998-07-01 | 2001-02-27 | Sigma-Aldrich Co. | Coagulation controls for prothrombin time (PT) and activated partial thromboplastin time (APTT) assays |
| DE19855819C2 (de) * | 1998-12-03 | 2001-02-15 | Roche Diagnostics Gmbh | Stabilisierung von Cytokeratin enthaltenden Kalibratoren |
| DE102005028018A1 (de) * | 2005-06-16 | 2006-12-21 | Dade Behring Marburg Gmbh | Verfahren zur Standardisierung von Gerinnungstesten |
| DE102006035580A1 (de) * | 2006-07-27 | 2008-02-14 | Csl Behring Gmbh | Bestimmung der biologischen Aktivität von Heparin in AT III-haltigen Präparationen |
| CN114813287A (zh) * | 2022-06-29 | 2022-07-29 | 深圳市帝迈生物技术有限公司 | 一种用于肝素抗凝检测的校准品及其制备方法 |
| CN118549662A (zh) * | 2023-02-24 | 2024-08-27 | 广州达安基因股份有限公司 | 抗凝血酶ⅲ质控品的制备方法及抗凝血酶ⅲ质控品 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3030272A (en) * | 1960-05-26 | 1962-04-17 | Abbott Lab | Stable heaparin solution |
| DE2461969A1 (de) * | 1974-12-31 | 1976-07-08 | Behringwerke Ag | Stabiles blutplasma, verfahren zu dessen herstellung und seine verwendung als vergleichsplasma bei gerinnungs- untersuchungen |
| US3985618A (en) * | 1975-05-02 | 1976-10-12 | Irving Innerfield | Method for detection of thrombosis and prethrombosis |
| DE2601372C3 (de) * | 1976-01-15 | 1980-03-27 | Behringwerke Ag, 3550 Marburg | Verfahren zur Bestimmung von Antithrombin III |
| US4067777A (en) * | 1976-05-13 | 1978-01-10 | Innerfield Irving | Determination of heparin in the blood |
| CH634662A5 (de) * | 1976-05-28 | 1983-02-15 | Pentapharm Ag | Verwendung von tripeptidderivaten zur quantitativen bestimmung von plasminogen-aktivatoren. |
| US4090977A (en) * | 1976-11-22 | 1978-05-23 | Research Corporation | Osmotically balanced anticoaglant |
| US4127502A (en) * | 1977-06-10 | 1978-11-28 | Eastman Kodak Company | Stabilizers for reconstituted, lyophilized samples |
| DE2812943C3 (de) * | 1978-03-23 | 1981-05-14 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren und Reagens zur Bestimmung der biologischen Aktivität von Heparin im Plasma |
| US4216117A (en) * | 1978-05-15 | 1980-08-05 | Bonderman Dean P | Lipoprotein diluent or solution and method useful in the preparation of assay reference materials |
| US4195072A (en) * | 1978-07-05 | 1980-03-25 | Abbott Laboratories | Stabilized platelet factor 4 immunoassay standards |
-
1979
- 1979-01-31 DE DE2903701A patent/DE2903701C2/de not_active Expired
-
1980
- 1980-01-09 US US06/110,581 patent/US4301028A/en not_active Expired - Lifetime
- 1980-01-17 EP EP80100222A patent/EP0014349B1/de not_active Expired
- 1980-01-17 DE DE8080100222T patent/DE3060262D1/de not_active Expired
- 1980-01-17 AT AT80100222T patent/ATE836T1/de not_active IP Right Cessation
- 1980-01-30 JP JP885980A patent/JPS55103463A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| EP0014349A1 (de) | 1980-08-20 |
| JPS55103463A (en) | 1980-08-07 |
| EP0014349B1 (de) | 1982-04-07 |
| US4301028A (en) | 1981-11-17 |
| DE2903701C2 (de) | 1980-10-16 |
| DE3060262D1 (en) | 1982-05-19 |
| JPS6342228B2 (de) | 1988-08-22 |
| DE2903701B1 (de) | 1980-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3060262D1 (en) | Control reagent for the determination of the activity of heparin | |
| DE3850002D1 (de) | Stabilisierung von Deferoxamin für die Chelatbildung mit freien Ionen in physiologischem Serum. | |
| IT8249401A0 (it) | Metodo per determinare la presenza di analita in soluzione, in particolare per saggi immunologici | |
| DE3575075D1 (de) | Waermeaustauscher mit sauerstoffanreicherung fuer blut. | |
| DE3582925D1 (de) | Auffangbehaelter fuer venoeses blut. | |
| FI890526A7 (fi) | Analyyttikonsentraation määritys käyttäen kahta leimausainetta | |
| SE8206168L (sv) | Peptidpreparat | |
| DE3675425D1 (de) | Nachweiskammer fuer blut. | |
| IT7928370A0 (it) | Procedimento per determinare l'emoglobina glicosilata in campioni di sangue. | |
| ATE86668T1 (de) | Antidiabetikaverbindungen. | |
| ATE221203T1 (de) | Bestimmung von glykosyliertem hämoglobin durch dämpfung der fluoreszenz | |
| ES485763A1 (es) | Un metodo directo para la determinacion de hierro en suero sanguineo | |
| GB2154735B (en) | Reagent for determining blood glucose content | |
| ATE49214T1 (de) | Platinkomplexe von aliphatischen tricarbonsaeuren. | |
| FI860555A7 (fi) | Pesuaineen tehostesuola. | |
| ATE87662T1 (de) | Antidiabetikaverbindungen. | |
| FI854627A7 (fi) | Menetelmä ja reagenssi plasmassa, seerumissa tai kokoveressä olevan vapaan tyroksiinin kvantitatiiviseksi määrittämiseksi. | |
| DE3585360D1 (de) | Mit lichtstrahlen arbeitendes koordinatenermittlungssystem. | |
| DE3889718D1 (de) | Maltooligosaccharid-Derivate und -Reagenzien für die Bestimmung von Amylase-Aktivität. | |
| DE3581731D1 (de) | Waessrige systeme, die aminosulfonsaeurederivate von carbonsaeuren enthalten. | |
| DE3582408D1 (de) | Cyanidfreies haemoglobinreagens. | |
| NO850773L (no) | Fremgangsmaate til aa absorbere so2 i vandig fosfatopploesning | |
| DE3764608D1 (de) | Festkoerperelektrode zur bestimmung von natriumionen-konzentrationen in loesungen. | |
| DE69426028D1 (de) | Reagenz für die enzymatische Bestimmung des Bikarbonatgehalts in Blutserum | |
| IT8120859A0 (it) | Procedimento per la realizzazione di un reattivo cromogeno per la determinazione del ferro e della capacita' ferrolegante nel siero, nonche' reattivo cromogeno ottenuto. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EELA | Cancelled due to lapse of time |